Krista Conger reports on the murky ethics surrounding unapproved stem cell "clinics" overseas:
This tension between patients who believe they have the right to undergo any procedure they hope will help them and the government agencies and scientists who wish to bar practitioners from providing unproven treatments is not going to be easily resolved, in part because “right” answers in cases like these are hard to come by. What seems clear-cut on paper — experimental treatments shouldn’t be marketed for large amounts of money to desperate patients — can be upended in the presence of a person with a life-threatening illness whose personal risk-versus-benefit equation is so different from your own.
The Dish 